Joint disease is among the most common sources of chronic pain in companion dogs, and understanding the evidence base for joint supplements helps owners make informed welfare decisions for affected animals.
Chronic joint pain from osteoarthritis is one of the most significant welfare problems affecting companion dogs, particularly in middle-aged to senior large breed individuals. The welfare impact extends beyond physical discomfort: dogs in chronic pain show behavioral changes including reduced activity, social withdrawal, irritability, and reluctance to engage in previously enjoyed activities. The evidence base for joint supplements is uneven, with omega-3 fatty acids showing the clearest anti-inflammatory benefit and glucosamine and chondroitin showing more modest and variable effects across trials. However, the most impactful welfare intervention for arthritic dogs is maintaining a lean body weight, which dramatically reduces mechanical load on damaged joints. Veterinary pain management using NSAIDs and newer biologics targeting nerve growth factor offers significant relief and should be considered proactively rather than reactively for dogs showing signs of joint discomfort.